A61K 9/0048
Eye
Official title: {Eye, e.g. artificial tears}
A61K9/0048 (Eye) appears on 5,021 US grants and 9,040 published applications in this corpus.
Search patents in A61K- Granted patents
- 5,021
- Published applications
- 9,040
- Assignees
- 2,409
- Inventors
- 10,212
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 22 | 0 |
| 1977 | 7 | 0 |
| 1978 | 8 | 0 |
| 1979 | 14 | 0 |
| 1980 | 10 | 0 |
| 1981 | 10 | 0 |
| 1982 | 7 | 0 |
| 1983 | 10 | 0 |
| 1984 | 14 | 0 |
| 1985 | 11 | 0 |
| 1986 | 8 | 0 |
| 1987 | 9 | 0 |
| 1988 | 15 | 0 |
| 1989 | 23 | 0 |
| 1990 | 22 | 0 |
| 1991 | 19 | 0 |
| 1992 | 26 | 0 |
| 1993 | 39 | 0 |
| 1994 | 39 | 0 |
| 1995 | 38 | 0 |
| 1996 | 59 | 0 |
| 1997 | 45 | 0 |
| 1998 | 48 | 0 |
| 1999 | 50 | 0 |
| 2000 | 35 | 0 |
| 2001 | 70 | 22 |
| 2002 | 86 | 107 |
| 2003 | 72 | 112 |
| 2004 | 42 | 170 |
| 2005 | 37 | 207 |
| 2006 | 46 | 198 |
| 2007 | 33 | 246 |
| 2008 | 29 | 238 |
| 2009 | 45 | 232 |
| 2010 | 75 | 284 |
| 2011 | 81 | 275 |
| 2012 | 147 | 307 |
| 2013 | 193 | 377 |
| 2014 | 245 | 422 |
| 2015 | 247 | 409 |
| 2016 | 245 | 473 |
| 2017 | 294 | 473 |
| 2018 | 284 | 483 |
| 2019 | 309 | 519 |
| 2020 | 312 | 593 |
| 2021 | 325 | 595 |
| 2022 | 298 | 525 |
| 2023 | 243 | 533 |
| 2024 | 266 | 501 |
| 2025 | 251 | 416 |
| 2026 | 158 | 323 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Polysaccharide encapsulated oxygen nanobubbles6 Oct 2026US 12,751,927 B2The Board of Trustees of the University of Illinois
- Topical ocular delivery of cromakalim6 Oct 2026US 12,751,939 B2Mayo Foundtation for Medical Education and Research
- OPA1 antisense oligomers for treatment of conditions and diseases6 Oct 2026US 12,753,408 B2Stoke Therapeutics, Inc.
- Elastomeric matrices based on plasticized PVOH compositions and uses thereof22 Sep 2026US 12,740,939 B2aVISI Ltd.
- Ophthalmic pharmaceutical compositions of roflumilast22 Sep 2026US 12,740,941 B2Iolyx Therapeutics, Inc.
- Suspension containing heterocyclidene acetamide derivative8 Oct 2026US 2026/0306401 A1Mochida Pharmaceutical Co., Ltd.
- Compositions, methods of treatment, and containers including compositions8 Oct 2026US 2026/0306427 A1
- Sulfurized imidazoles in ophthalmic formulations8 Oct 2026US 2026/0306431 A1Geneiii Biotech Company Ltd.
- Water-based liquid preparation8 Oct 2026US 2026/0306443 A1Senju USA, Inc.
- Sulfurized imidazoles in ophthalmic formulations8 Oct 2026US 2026/0306457 A1Geneiii Biotech Company Ltd.
Most cited
By later US patents
- Drug releasing biodegradable fiber implant1,662US 6,596,296 B1Board of Regents, The University of Texas System · 2003
- Low-permeability, laser-activated drug delivery device1,367US 8,911,426 B2On Demand Therapeutics, Inc. · 2014
- Drug delivery devices, kits and methods therefor1,366US 8,521,273 B22013
- Controlled-release biocompatible ocular drug delivery implant devices and methods780US 6,331,313 B1Oculex Pharmaceticals, Inc. · 2001
- Biocompatible ocular implants713US 5,443,505 AOculex Pharmaceuticals, Inc. · 1995